Equities

Belluscura PLC

BELL:LSE

Belluscura PLC

Health CareMedical Equipment and Services
  • Price (GBX)10.25
  • Today's Change0.00 / 0.00%
  • Shares traded103.10k
  • 1 Year change-63.39%
  • Beta1.2521
Data delayed at least 20 minutes, as of Nov 01 2024 16:27 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Belluscura PLC's revenues fell -40.96% from 1.40m to 825.41k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 8.15m to a larger loss of 18.52m.
Gross margin-33.28%
Net profit margin-1,030.73%
Operating margin-971.00%
Return on assets-76.44%
Return on equity-85.01%
Return on investment-84.73%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Belluscura PLC fell by 1.11m. Cash Flow from Financing totalled 12.51m or 1,515.77% of revenues. In addition the company used 9.13m for operations while cash used for investing totalled 4.53m.
Cash flow per share-0.0782
Price/Cash flow per share--
Book value per share0.0905
Tangible book value per share0.0376
More ▼

Balance sheet in USDView more

Belluscura PLC uses little or no debt in its capital structure.
Current ratio3.25
Quick ratio2.09
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.